Preoperative prediction of Ki-67 and p53 status in meningioma using a multiparametric MRI-based clinical-radiomic model
Frontiers in Oncology · 23.05.2023 · 13
DOI: 10.3389/fonc.2023.1138069 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Oncology, online erschienen am 23.05.2023. Verfasst von Chung-Man Moon und 8 weiteren Autor:innen. Beteiligte Einrichtung: Research Institute of Medical Sciences, Chonnam National University, Gwangju, Republic of Korea. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Science and ICT, South Korea.
Abstract (Originalsprache)
Purpose
To investigate the utility of preoperative multiparametric magnetic resonance imaging (mpMRI)-based clinical-radiomic analysis combined with machine learning (ML) algorithms in predicting the expression of the Ki-67 proliferative index and p53 tumor suppressor protein in patients with meningioma.
Methods
This multicenter retrospective study included 483 and 93 patients from two centers. The Ki-67 index was classified into high (Ki-67≥5%) and low (Ki-67<5%)-expressed groups, and the p53 index was classified into positive (p53≥5%) and negative (p53<5%)-expressed groups. Clinical and radiological features were analyzed using univariate and multivariate statistical analyses. Six ML models were performed with different types of classifiers to predict Ki-67 and p53 status.
Results
In the multivariate analysis, larger tumor volumes (p<0.001), irregular tumor margin (p<0.001), and unclear tumor-brain interface (p<0.001) were independently associated with a high Ki-67 status, whereas the presence of both necrosis (p=0.003) and the dural tail sign (p=0.026) were independently associated with a positive p53 status. A relatively better performance was yielded from the model constructed by combined clinical and radiological features. The area under the curve (AUC) and accuracy of high Ki-67 were 0.820 and 0.867 in the internal test, and 0.666 and 0.773 in the external test, respectively. Regarding p53 positivity, the AUC and accuracy were 0.858 and 0.857 in the internal test, and 0.684 and 0.718 in the external test.
Conclusion
The present study developed clinical-radiomic ML models to non-invasively predict Ki-67 and p53 expression in meningioma using mpMRI features, and provides a novel non-invasive strategy for assessing cell proliferation.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Research Institute of Medical Sciences, Chonnam National University, Gwangju, Republic of Korea.
- Department of Radiology, Chonnam National University Hospital, Gwangju, Republic of Korea.
- Department of Artificial Intelligence Convergence, Chonnam National University, Gwangju, Republic of Korea.
- Department of Radiology, Chonnam National University Medical School, Gwangju, Republic of Korea.
- Department of Radiology, Chonnam National University Hwasun Hospital, Hwasun, Republic of Korea.
Förderung
- Ministry of Science and ICT, South Korea
Zitieren
APA
Moon, C. M., Lee, Y. Y., Kim, D. Y., Yoon, W., Baek, B. H., Park, J. H., Heo, S. H., Shin, S. S., & Kim, S. K. (2023). Preoperative prediction of Ki-67 and p53 status in meningioma using a multiparametric MRI-based clinical-radiomic model. Frontiers in Oncology, 13. https://doi.org/10.3389/fonc.2023.1138069
Vancouver
Moon CM, Lee YY, Kim DY, Yoon W, Baek BH, Park JH, et al. Preoperative prediction of Ki-67 and p53 status in meningioma using a multiparametric MRI-based clinical-radiomic model. Frontiers in Oncology. 2023;13. doi:10.3389/fonc.2023.1138069
BibTeX
@article{Moon2023,
author = {Moon, Chung-Man and Lee, Yun Young and Kim, Doo-Young and Yoon, Woong and Baek, Byung Hyun and Park, Jae-Hyun and Heo, Suk-Hee and Shin, Sang-Soo and Kim, Seul Kee},
title = {Preoperative prediction of Ki-67 and p53 status in meningioma using a multiparametric MRI-based clinical-radiomic model},
journal = {Frontiers in Oncology},
year = {2023},
volume = {13},
doi = {10.3389/fonc.2023.1138069}
}
EUVIMED